Chest configuration in children and adolescents with infantile nephropathic cystinosis compared with other chronic kidney disease entities and its clinical determinants.
Müller S, Kluck R, Jagodzinski C, Brügelmann M, Hohenfellner K, Büscher A, Kemper MJ, Fröde K, Oh J, Billing H, Thumfart J, Weber LT, Acham-Roschitz B, Arbeiter K, Tönshoff B, Hagenberg M, Pavičić L, Haffner D, Zivicnjak M.
Pediatr Nephrol. 2023 Dec;38(12):3989-3999. doi: 10.1007/s00467-023-06058-x. Epub 2023 Jul 7.
Idiopathic infantile hypercalcemia in children with chronic kidney disease due to kidney hypodysplasia.
Gurevich E, Borovitz Y, Levi S, Perlman S, Landau D.
Pediatr Nephrol. 2023 Apr;38(4):1067-1073. doi: 10.1007/s00467-022-05740-w. Epub 2022 Sep 26.
Autosomal Recessive Polycystic Kidney Disease.
Subramanian S, Leslie SW, Ahmad T.
2024 Mar 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
[Infantile polycystic kidney disease: a case report and literature review].
Luo F, Gu WZ, Chen Z, Shi LP, Ma XL, Lin HJ, Qiu YH.
Zhonghua Er Ke Za Zhi. 2013 May;51(5):377-81.
Renal Cyst (Archived).
Sigmon DF, Shikhman R, Nielson JL.
2023 Dec 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis.
Hohenfellner K, Nießl C, Haffner D, Oh J, Okorn C, Palm K, Schlingmann KP, Wygoda S, Gahl WA.
Mol Genet Metab. 2022 Aug;136(4):282-288. doi: 10.1016/j.ymgme.2022.06.009. Epub 2022 Jul 1.
Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis.
Nießl C, Boulesteix AL, Oh J, Palm K, Schlingmann P, Wygoda S, Haffner D, Wühl E, Tönshoff B, Buescher A, Billing H, Hoppe B, Zirngibl M, Kettwig M, Moeller K, Acham-Roschitz B, Arbeiter K, Bald M, Benz M, Galiano M, John-Kroegel U, Klaus G, Marx-Berger D, Moser K, Mueller D, Patzer L, Pohl M, Seitz B, Treikauskas U, von Vigier RO, Gahl WA, Hohenfellner K.
Mol Genet Metab. 2022 Aug;136(4):268-273. doi: 10.1016/j.ymgme.2022.06.010. Epub 2022 Jul 2.
Inherited non-FGF23-mediated phosphaturic disorders: A kidney-centric review.
Walker E, Hayes W, Bockenhauer D.
Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101843. doi: 10.1016/j.beem.2023.101843. Epub 2023 Nov 25.
Diagnosing Fabry nephropathy: the challenge of multiple kidney disease.
Esposito P, Caputo C, Repetto M, Somaschini A, Pietro B, Colomba P, Zizzo C, Parodi A, Zanetti V, Canepa M, Eustachi V, Sanguineri F, Mandich P, Viazzi F.
BMC Nephrol. 2023 Nov 21;24(1):344. doi: 10.1186/s12882-023-03388-8.
Morphological changes and their associations with clinical parameters in children with nephropathic cystinosis and chronic kidney disease prior to kidney replacement therapy over 25 years.
Brügelmann M, Müller S, Bohlen AV, Hohenfellner K, Büscher A, Kemper MJ, Fröde K, Kanzelmeyer N, Oh J, Billing H, Gellermann J, Müller D, Weber LT, Acham-Roschitz B, Arbeiter K, Tönshoff B, Hagenberg M, Žebec MS, Haffner D, Zivicnjak M.
Pediatr Nephrol. 2024 Oct;39(10):3067-3077. doi: 10.1007/s00467-024-06421-6. Epub 2024 Jun 8.
